Close Menu

Escherichia coli

NEW YORK (GenomeWeb News) – PathoGenetix today said it has signed a collaborative agreement with the US Food and Drug Administration to evaluate the company's technology for use in foodborne illness outbreak investigation and response.

NEW YORK (GenomeWeb News) – In a special issue of the Journal of the American Medical Association out today, researchers presented a set of studies, editorials, and viewpoint articles centered on a genomics theme.

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said today it has received a No Objection Letter from the US Department of Agriculture Food Safety and Inspection Service for its iQ-Check real-time PCR method for detecting Shiga toxin-producing Escherichia coli (STEC) bacteria in beef.

NEW YORK (GenomeWeb News) – A group of Canadian research organizations will jointly provide C$1 million (US$997,000) for research and development of a genomics-based test that can identify pathogenic E. coli bacteria found in the food production process, Genome Alberta said today.

NEW YORK (GenomeWeb News) – Life Technologies said today it received a Letter of No Objection from the US Department of Agriculture-Food Safety and Inspection Service for the firm's RapidFinder Shiga-toxin producing Escheria coli (STEC) Detection system.

DuPont Qualicon said this month that the US Department of Agriculture Food and Safety Inspection Service has approved the DuPont Qualicon BAX STEC assay for screening Shiga toxin-producing strains of Escherichia coli, or STEC.

Seegene and DuPont Nutrition & Health said today that they have inked an agreement to jointly develop highly multiplexed assays to detect foodborne pathogens by combining Seegene's real-time PCR and melt curve analysis technology with DuPont's benchtop BAX System.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.